TPMT (Thiopurine S-methyltransferase) variants and mutations

TPMT (also known as Thiopurine S-methyltransferase) is a human protein-coding gene encoding a thiopurine S-methyltransferase protein. It methylates and inactivates thiopurine metabolites, strongly influencing how much cytotoxic thioguanine nucleotide accumulates during therapy. Reduced-function alleles can cause profound myelosuppression at standard thiopurine doses, making genotype or enzyme activity clinically actionable. This analysis covers 388 TPMT variants and mutations. Of these, 96% have computational variant effect predictions. Disease context includes thiopurine S-methyltransferase deficiency, aging, and neurodegenerative disease. Example TPMT variants include G3D, G3S, and T4S.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.

Notable TPMT variants

Examples include G3D, G3S, T4S, R5S, D9N, I10M, I10S, I10V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.